These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20001878)

  • 1. A new paradigm for treating infections: "go hard and go home".
    Lipman J; Boots R
    Crit Care Resusc; 2009 Dec; 11(4):276-81. PubMed ID: 20001878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal nosocomial sepsis in a level-III NICU: evaluation of the causative agents and antimicrobial susceptibilities.
    Yalaz M; Cetin H; Akisu M; Aydemir S; Tunger A; Kültürsay N
    Turk J Pediatr; 2006; 48(1):13-8. PubMed ID: 16562780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic strategies in the treatment of infection in critically ill patients].
    Schierbeck J; Kolmos HJ
    Ugeskr Laeger; 2007 Feb; 169(8):699-702. PubMed ID: 17313920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of severe infections: should one always administer an aminoglycoside?].
    Cometta A; Baumgartner JD
    Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial management of sepsis and septic shock.
    Sharma S; Kumar A
    Clin Chest Med; 2008 Dec; 29(4):677-87, ix. PubMed ID: 18954702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing antimicrobial therapy in sepsis and septic shock.
    Kumar A
    Crit Care Clin; 2009 Oct; 25(4):733-51, viii. PubMed ID: 19892250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The choice of empirical antibiotic therapy for nosocomial pneumonia.
    Ramirez JA
    J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-negative bacterial resistance: evolving patterns and treatment paradigms.
    Kollef MH
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S85-8. PubMed ID: 15712101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-escalation therapy in ventilator-associated pneumonia.
    Niederman MS
    Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP
    Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L; Edén T
    Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.